In individuals with obesity, lower IGF-1 serum levels and a blunted response to GH-stimulating dynamic tests are associated with more significant metabolic impairment and even morpho-functional cardiological alterations [52]. This evidence concerns the gene GH1 and obesity due to melanocortin 4 receptor deficiency.